UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
UAB Hospital is the first in Alabama to offer the Nanostim leadless pacemaker for patients with bradycardia.
Pediatric cancer researcher Gregory Friedman, M.D., receives $40,000 grant to fight brain cancer in children.
A federally funded study shows how invading glioma cells disrupt brain connections and break down the blood brain barrier.
Crawford Downs, Ph.D., has been named chair-elect of the Animals in Research Committee of the Association for Research in Vision Science and Ophthalmology.
The University of Alabama Board of Trustees approved the creation of the Personalized Medicine Institute, the Institute for Informatics and the UAB-HudsonAlpha Center for Genomic Medicine.
The UAB-HudsonAlpha Center for Genomic Medicine will span human genome research with clinical care.
Neurologist David Geldmacher, M.D., is  launching a new clinical effort to prepare a personalized dementia risk assessment for people concerned about their risk for developing memory problems as they age.
Anthony Nicholas, M.D., associate professor in the Department of Neurology, is a co-editor of the first textbook on the subject of protein deimination in human health and disease.
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.